- Country: Ukraine
- Summary: Cpv: 33600000-6 Pharmaceutical Products (Paracetamol (Acetaminophen) 10 Mg/Ml in 100 Ml)
- UAT Ref No: 62529625
- Deadline: 25 Feb 2022
- Financier: Self Financed
- Purchaser Ownership: Government
- Tender Value: UAH 1349660
- Notice Type: Tender
- Document Ref. No.: UA-2022-01-25-017865-b
- Purchaser's Detail:Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details.
- Description:
- Tenders are invited for Cpv: 33600000-6 Pharmaceutical Products (Paracetamol (Acetaminophen) 10 Mg/Ml in 100 Ml) Plan: 1 349 660,00 UAH without VAT Minimum step size: 6 748,30 UAH Clarification: from 2022-01-25 20:52:08 to 2022-02-15 03:30:00 Bids submission: from 2022-01-25 20:52:08 to 2022-02-25 13:30:00 Appeals: from 2022-01-25 20:52:08 to 2022-02-21 03:30:00 [Disclaimer: The above text is machine translated. For accurate information kindly refer the original document.]
- Documents:
If you are registered member, kindly login to view full details of this tender notice:
CLICK HERE TO LOGINCpv: 33600000-6 Pharmaceutical Products (Paracetamol (Acetaminophen) 10 Mg/Ml in 100 Ml) - Ukraine Tender
The STATE ENTERPRISE MEDICAL PROCUREMENT OF UKRAINE, a Government sector organization in Ukraine, has announced a new tender for Cpv: 33600000-6 Pharmaceutical Products (Paracetamol (Acetaminophen) 10 Mg/Ml in 100 Ml). This tender is published on UkraineTenders under UAT Ref No: 62529625 and is categorized as a Tender. Interested and eligible suppliers are invited to participate by reviewing the tender documents and submitting their bids before the deadline on 2022-02-25.
The estimated tender value is UAH 1349660, and full details, including technical specifications and submission requirements, are provided in the official tender documents. Ensure all submissions meet the criteria outlined to be considered for evaluation.
